ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Graft failure"

  • 2022 American Transplant Congress

    Comparison of Outcomes in High Donation After Circulatory Death Liver Transplantation Usage Centers in the Acuity Circles Era

    L. Chau1, A. Mohamed2, T. Kitajima1, K. Collins3, M. Rizzari1, A. Yoshida4, M. Abouljoud3, S. Nagai1

    1Henry Ford Hospital, Detroit, MI, 2Department of Transplant and Hepatobiliary Surgery, Henry Ford Hospital, Detroit, MI, 3Henry Ford Transplant Institute, Detroit, MI, 4Henry Ford Hospital, Grosse Pointe, MI

    *Purpose: The recent acuity circles (AC) liver allocation policy has increased rates of donation after circulatory death (DCD) liver transplantation. We hypothesize transplant centers with…
  • 2022 American Transplant Congress

    Fibrinolysis Shutdown Subtype of Early Allograft Dysfunction Represents the Predominant Cohort of Patients with Graft Failure Following Liver Transplantation

    H. B. Moore1, T. L. Nydam2, M. Adams3, T. Ferrell1, I. Rodriguez4, D. Yoeli1, R. Choudhury1, J. Pomposelli1, E. A. Pomfret1

    1University of Colorado, Aurora, CO, 2Univeristy of Colorado, Aurora, CO, 3Childrens Hospital Colorado, Aurora, CO, 4University of Colorado Anschutz Medical Campus, Aurora, CO

    *Purpose: Early allograft dysfunction (EAD) is associated with an increased rate of graft failure in liver transplantation (LT), but a mechanism remains unclear. Recent experience…
  • 2022 American Transplant Congress

    A Novel Mismatch That Modulates the Innate Alloresponse Risk Stratifies Renal Transplant Patients

    H. Dai, K. Abou Daya, M. Oberbarnscheidt, R. Mehta, C. Macedo, D. Metes, Q. Xu, A. Zeevi, P. Randhawa, F. Lakkis, A. Cherukuri

    Thomas E. Starzl Transplantation Institute, UPMC, Pittsburgh, PA

    *Purpose: Donor polymorphism in the gene encoding signal regulatory protein alpha (SIRPα) is a key modulator of the recipient’s innate alloresponse. Here, we investigated the…
  • 2022 American Transplant Congress

    Association Between CT Measurements of Body Composition Before Liver Transplantation and Post-Transplantation Outcomes

    Y. Liu1, O. Shafaat1, K. Jackson1, J. Motter1, B. Boyarsky1, M. Latif1, F. Yuan1, E. King1, A. Zaheer1, R. Summers2, D. Segev1, M. McAdams-DeMarco1, C. Weiss1

    1Johns Hopkins University, Baltimore, MD, 2NIH Clinical Center, Bethesda, MD

    *Purpose: Various methods exist for measuring body composition using computed tomography (CT) scans; however, it is unclear which components best predict post-liver transplantation (LT) outcomes.…
  • 2022 American Transplant Congress

    Predictors of Delayed Kidney Graft Function Following Combined Liver and Kidney Transplantation

    P. Vincenzi1, J. Gaynor2, R. Vianna3, G. Ciancio3

    1General Surgery, Ospedali Riuniti Marche Nord, Pesaro, Italy, 2General Surgery, Miami Transplant Institute, Miami, FL, 3Transplant Surgery, Miami Transplant Institute, Miami, FL

    *Purpose: Combined liver and kidney transplantation (CLKT) improves the survival in liver transplant recipients with renal dysfunction. However, kidney DGF (kDGF) still represents a common…
  • 2022 American Transplant Congress

    Real-Time Application of Deep Learning in Diagnosis of Graft Fibrosis After Liver Transplantation Using Longitudinal Data

    A. Azhie1, D. Sharma2, P. Sheth1, W. Xu3, M. Bhat1

    1Ajmera Transplant Program, University Health Network, Toronto, ON, Canada, 2Department of Biostatistics, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada, 3Biostatistics Division, Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada

    *Purpose: Graft fibrosis develops insidiously in liver transplant recipients and is associated with worse survival. Early detection of fibrosis is essential to avoid further progression…
  • 2022 American Transplant Congress

    Predicting Long Term Kidney-Allograft Failure: Machine Learning vs Traditional Statistical Models

    A. Truchot1, M. Raynaud1, c. lefaucheur2, O. Aubert1, A. Loupy1

    1Paris Transplant Group, Paris, France, 2Hôpital Saint-Louis, Paris, France

    *Purpose: Prognostic models have been developed in organ transplant over the past years using traditional statistical models. However, whether these are outperformed by machine learning…
  • 2022 American Transplant Congress

    Infections Following Rejection Therapies in Solid Organ Transplant Recipients

    S. Gupta1, J. Gea-Banacloche2, H. Me3, D. M. Chascsa4, H. R. Vikram2, R. Yaman1, L. Kodali3

    1Internal Medicine, Mayo Clinic, Scottsdale, AZ, 2Infectious Diseases, Mayo Clinic, Phoenix, AZ, 3Transplant Nephrology, Mayo Clinic, Phoenix, AZ, 4Hepatology, Mayo Clinic, Phoenix, AZ

    *Purpose: Infections are known complications of solid-organ transplant. They are most prevalent in the first 12 months after transplant when immunosuppression is at its peak.…
  • 2022 American Transplant Congress

    Implementing Clinical Decision Support Tools for Immunosuppressant Drug-Drug Interactions to Prevent Graft Failure

    A. Yishak1, S. Ledan2, S. Mukherjee3, C. Chen2, A. Ayoola2, T. Kim2, A. Olenik2, K. Mullican2, A. Henje2, N. Lorence2, L. Beckman2

    1MAPMG, Mc Lean, VA, 2Kaiser Permanente, Silver Spring, MD, 3MAPMG, Rockville, MA

    *Purpose: Immunosuppressant drug-drug interactions can result in immunosuppressant toxicity or subtherapeutic levels causing rejection. If not identified and managed appropriately, these interactions may result in…
  • 2022 American Transplant Congress

    Development of a Radiomics-Based Model to Predict Graft Fibrosis in Liver Transplant Recipients: A Pilot Study

    F. Qazi Arisar1, E. Salinas-Miranda2, H. Ale Ali2, K. Lajkosz3, C. Chen1, A. Azhie1, G. M. Healy2, D. Deniffel2, M. A. Haider2, M. Bhat1

    1Ajmera Transplant Program, University Health Network, Toronto, ON, Canada, 2Lunenfeld Tanenbaum Research Institute, Toronto, ON, Canada, 3Department of Biostatistics, University Health Network, Toronto, ON, Canada

    *Purpose: Recurrent fibrosis complicates 40% of Liver transplants (LT), compromising long-term survival. We evaluated the ability of a model combining radiomic features on CT scans…
  • « Previous Page
  • 1
  • …
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • 55
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences